Pharmacological inhibition or genetic depletion of LSD1 induces differentiation of MLL-driven AML stem cells and of other genetically defined AML subtypes (Maiques-Diaz et al., 2018). The gene discussed is KMT2A; the disease is acute myeloid leukemia.